Table 2. BCL-2 expression in HRS cells... | American Society of Hematology

Table 2.

BCL-2 expression in HRS cells according to the histologic type

Histologic type	No.	BCL-2⁺tumors		Intensity of BCL-2 expression
Histologic type	No.	No.	%	Weak, %	Strong, %
All tumors	707	433	61	36	25
Nodular sclerosis	551	359	65^*	38	27^†
Mixed cellularity	143	67	47^*	31	16^†
Lymphocyte depletion	5	5	100	40	60
Unclassified cHD	8	1	13	13	0

Histologic type	No.	BCL-2⁺tumors		Intensity of BCL-2 expression
Histologic type	No.	No.	%	Weak, %	Strong, %
All tumors	707	433	61	36	25
Nodular sclerosis	551	359	65^*	38	27^†
Mixed cellularity	143	67	47^*	31	16^†
Lymphocyte depletion	5	5	100	40	60
Unclassified cHD	8	1	13	13	0

P < .0001 by Fisher exact test (nodular sclerosis versus mixed cellularity).

P = .0006 by χ² test (strong versus weak versus negative).